- Home
- Clinical Trials
Cardiovascular Disease Study Melbourne J3L
Cardiovascular Disease Study
Sunshine Melbourne
Do you have cardiovascular disease? We are looking for volunteers to participate in a research study to investigate the effect of an investigational treatment on the reduction of major adverse cardiovascular events such as heart disease and strokes in adults with elevated lipoprotein(a).
Description
What to expect
Study details
Ages
18 + years old
Duration
Approx 2 years
Compensation
All treatments and procedures are free, and participants will be reimbursed for reasonable expenses associated with study visits.
Eligibility Criteria
You may be eligible to take part if you:
- Be aged 18 years of age and older.
- Have established cardiovascular disease or are at risk for a first cardiovascular event.
- Have an Lp(a) laboratory measurement that is equal to or more than 175 nmol/L.
Locations
Description
We are conducting a research study to test the efficacy of a new investigational treatment for adults with high levels of lipoprotein(a).
Scientific evidence strongly suggests that having high levels of a substance called lipoprotein (a) [Lp(a)] can significantly increase the risk of heart and blood vessel problems like heart disease and strokes. This risk seems to be independent of other factors and is even linked to conditions like kidney disease and valve problems in the heart.
Interestingly, unlike some other factors that affect heart health, such as diet or exercise, Lp(a) levels aren’t easily influenced by lifestyle changes or medications that lower cholesterol. Even when people take medications like statins, which are meant to reduce heart risks, high Lp(a) levels can still pose a danger.
What to expect
Here at Momentum, we are studying an investigational treatment (LY3819469) which aims to reduce lipoprotein (a) and reduce the occurrence of serious heart events like heart attacks or strokes.
The investigational treatment could help improve heart health by reducing the risk of major heart problems in adults with high levels of lipoprotein (a) [Lp(a)]. This research aims to see how LY3819469 affects the occurrence of serious heart events like heart attacks or strokes in adults who either already have heart disease or are at risk for it. By studying this, we hope to gather more evidence about how LY3819469 could benefit people in this group.
All treatments and procedures are free, and participants will be reimbursed for reasonable expenses associated with study visits.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
*You can unsubscribe or opt out at any time.
- We collect personal information, such as your name, address and contact details, and details of your medical conditions, that enables us to identify if you may be eligible to participate in a current or future study. On occasion we may also contact people on our database by email, with general news and information relevant to our studies and volunteers. By submitting this form you agree to receive email and text notifications about this and other enrolling studies. You can unsubscribe or opt out at any time. We do not sell, share or distribute our database under any circumstances.
- We will collect this information directly from you. If you consent to release of medical records, we will obtain medical information from other agencies on your behalf if these are required for your participation in any clinical study at Momentum Clinical Research.
- Security of your information is important. Personal information collected is stored by third party data storage providers. We believe these providers offer safe and secure systems.
- All information we collect about you will be treated with confidentiality and can be accessed only by Momentum Clinical Research employees.
- By completing our online enrolment form, or any other forms we send you, you agree to us holding your personal details within our databases.
- There is no obligation for you to participate in a study that we contact you about. If you decline to participate in a study, that will not affect your eligibility for participation in another study.